Guangdong Zhongsheng Pharmaceutical Hits Day High with 4.49% Surge

Guangdong Zhongsheng Pharmaceutical Co., Ltd. has experienced a notable increase of 4.49% on March 24, 2026, reaching an intraday high of CNY 17.47. This performance stands out against the backdrop of the China Shanghai Composite, which rose by 1.78% on the same day. Over the past year, Guangdong Zhongsheng has delivered a remarkable return of 57.81%, significantly outperforming the broader market's 15.17% gain. However, the stock has faced challenges in the short term, with a decline of 3.32% over the past week and an 8.05% drop in the last month. Financial metrics indicate a mixed performance; while the company has shown impressive growth in pre-tax and net profits for the latest quarter, its long-term growth has been hindered by a decline in operating profit over the past five years. The stock's current dividend yield stands at 1.25%, and it is trading at a market capitalization of CNY 13,697 million. Despite the recent gains, the stock's valuation remains a point of concern, reflecting a complex financial landscape for investors.